{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:41:05Z","timestamp":1780760465709,"version":"3.54.1"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T00:00:00Z","timestamp":1632441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Previously, it was reported that multiple patients had hemolytic anemia associated with cimetidine administration, while only one patient who had received intravenous cimetidine was serologically diagnosed with drug-induced immune hemolytic anemia (DIIHA) caused by cimetidine-dependent antibodies. However, the ability of oral cimetidine intake to induce the production of antibodies has not been examined. In this study, we report a 44-year-old male patient in whom oral cimetidine administration resulted in cimetidine-dependent antibodies and drug-independent non-specific antibodies, leading to the development of DIIHA. Serological tests showed that the results of direct antiglobulin test (DAT) for anti-IgG (3+) and anti-C3d (1+) were positive. The IgM and IgG cimetidine-dependent antibodies (the highest total titer reached 4,096) were detected in the plasma incubated with O-type RBCs and 1 mg\/mL cimetidine or the plasma incubated with cimetidine-coated RBCs. IgG-type drug-independent non-specific antibodies were detected in blood samples collected at days 13, 34, 41, and 82 post-drug intake. This is the first study to report that oral administration of cimetidine can elicit the production of cimetidine-dependent antibodies, leading to DIIHA, and the production of drug-independent non-specific antibodies, resulting in hemolytic anemia independent of cimetidine. Presence of pathogenic antibodies were detectable longer than 41 days. This suggests that patients with DIIHA caused by cimetidine need to be given necessary medical monitoring within 41 days after cimetidine intake.<\/jats:p>","DOI":"10.3389\/fmed.2021.723167","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T18:49:32Z","timestamp":1632768572000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Case Report: Oral Cimetidine Administration Causes Drug-Induced Immune Hemolytic Anemia by Eliciting the Production of Cimetidine-Dependent Antibodies and Drug-Independent Non-specific Antibodies"],"prefix":"10.3389","volume":"8","author":[{"given":"Yuanjun","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajie","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baochan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.blre.2010.06.004","article-title":"Immune hemolytic anemia associated with drug therapy","volume":"24","author":"Garratty","year":"2010","journal-title":"Blood Rev"},{"key":"B2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.21307\/immunohematology-2019-100","article-title":"Drugs that have been shown to cause drug-induced immune hemolytic anemia or positive direct antiglobulin tests: some interesting findings since 2007","volume":"30","author":"Garratty","year":"2014","journal-title":"Immunohematology."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1111\/trf.15151","article-title":"The first reported case of drug-induced hemolytic anemia caused by dimethyl fumarate in a patient with multiple sclerosis","volume":"59","author":"Quintanilla-Bord\u00e1s","year":"2019","journal-title":"Transfusion"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1182\/bloodadvances.2020001726","article-title":"Bendamustine-induced immune hemolytic anemia: a case report and systematic review of the literature","volume":"4","author":"Chan","year":"2020","journal-title":"Blood Adv."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1111\/trf.15226","article-title":"Etoricoxib-induced immune hemolytic anemia: first case presenting acute kidney failure","volume":"59","author":"Burgos Pratx","year":"2019","journal-title":"Transfusion."},{"key":"B6","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1097\/QAD.0000000000002425","article-title":"Drug-induced immune hemolytic anemia because of efavirenz: a case report","volume":"34","author":"Lin","year":"2020","journal-title":"AIDS."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1111\/trf.16360","article-title":"Serologic characteristics of oxaliplatin antibodies in 15 patients with drug-induced immune hemolytic anemia","volume":"61","author":"Nguyen","year":"2021","journal-title":"Transfusion."},{"key":"B8","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s40199-020-00386-1","article-title":"Bosentan-induced immune hemolytic anemia in 17 years old man. A case report","volume":"29","author":"Afra","year":"2021","journal-title":"Daru"},{"key":"B9","doi-asserted-by":"publisher","first-page":"697192","DOI":"10.3389\/fmed.2021.697192","article-title":"Case report: drug-induced immune haemolytic anaemia caused by cefoperazone-tazobactam\/ sulbactam combination therapy","volume":"8","author":"Wu","year":"2021","journal-title":"Front Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"105","DOI":"10.21307\/immunohematology-2019-328","article-title":"An update on drug-induced immune hemolytic anemia","volume":"23","author":"Garratty","year":"2007","journal-title":"Immunohematology."},{"key":"B11","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1517\/14740338.2012.678832","article-title":"Immune hemolytic anemia caused by drugs","volume":"11","author":"Garratty","year":"2012","journal-title":"Expert Opin Drug Saf."},{"key":"B12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.21307\/immunohematology-2019-098","article-title":"Drug-induced immune hemolytic anemia: the last 30 years of changes","volume":"30","author":"Arndt","year":"2014","journal-title":"Immunohematology."},{"key":"B13","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1046\/j.1365-2141.1998.00615.x","article-title":"Positive direct antiglobulin tests and haemolytic anaemia following therapy with beta-lactamase inhibitor containing drugs may be associated with nonimmunologic adsorption of protein onto red blood cells","volume":"100","author":"Garratty","year":"1998","journal-title":"Br J Haematol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1046\/j.1423-0410.2003.00323.x","article-title":"Positive direct antiglobulin tests and haemolytic anaemia following therapy with the beta-lactamase inhibitor, tazobactam, may also be associated with non-immunologic adsorption of protein onto red blood cells","volume":"85","author":"Arndt","year":"2003","journal-title":"Vox Sang."},{"key":"B15","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/j.1537-2995.2008.02028.x","article-title":"Positive direct and indirect antiglobulin tests associated with oxaliplatin can be due to drug antibody and\/or drug-induced nonimmunologic protein adsorption","volume":"49","author":"Arndt","year":"2009","journal-title":"Transfusion."},{"key":"B16","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/medsci6020030","article-title":"Cimetidine: a safe treatment option for cutaneous warts in pediatric heart transplant recipients","volume":"6","author":"Das","year":"2018","journal-title":"Med Sci (Basel)."},{"key":"B17","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.intimp.2019.02.026","article-title":"Immunomodulatory properties of cimetidine: its therapeutic potentials for treatment of immune-related diseases","volume":"70","author":"Jafarzadeh","year":"2019","journal-title":"Int Immunopharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1001\/jamadermatol.2016.2303","article-title":"Novel treatment using cimetidine for erythropoietic protoporphyria in children","volume":"152","author":"Tu","year":"2016","journal-title":"JAMA Dermatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1001\/jama.2013.280490","article-title":"Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency","volume":"310","author":"Lam","year":"2013","journal-title":"JAMA"},{"key":"B20","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0140-6736(79)91637-4","article-title":"Autoimmune haemolytic anaemia associated with cimetidine","volume":"2","author":"Rotoli","year":"1979","journal-title":"Lancet."},{"key":"B21","doi-asserted-by":"publisher","first-page":"795","DOI":"10.7326\/0003-4819-91-5-795","article-title":"Cimetidine and hematologic effects","volume":"91","author":"Rate","year":"1979","journal-title":"Ann Intern Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/00004836-198310000-00006","article-title":"Cimetidine-induced hemolytic anemia: the fallacy of clinical associations","volume":"5","author":"Petz","year":"1983","journal-title":"J Clin Gastroenterol."},{"key":"B23","first-page":"156","article-title":"Auto-immune hemolytic anemia during treatment with cimetidine","volume":"70","author":"Tan-Ngamtrong","year":"1987","journal-title":"J Med Assoc Thai."},{"key":"B24","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/j.1537-2995.2009.02447.x","article-title":"Immune hemolytic anemia due to cimetidine: the first example of a cimetidine antibody","volume":"50","author":"Arndt","year":"2010","journal-title":"Transfusion."},{"key":"B25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.21307\/immunohematology-2019-102","article-title":"How we investigate drug-induced immune hemolytic anemia","volume":"30","author":"Leger","year":"2014","journal-title":"Immunohematology."},{"key":"B26","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/nutrit\/nuy053","article-title":"Dietary restrictions for people with glucose-6-phosphate dehydrogenase deficiency","volume":"77","author":"La Vieille","year":"2019","journal-title":"Nutr Rev."},{"key":"B27","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/ejh.13432","article-title":"COVID-19 infection and treatment with hydroxychloroquine cause severe haemolysis crisis in a patient with glucose-6-phosphate dehydrogenase deficiency","volume":"105","author":"Beauverd","year":"2020","journal-title":"Eur J Haematol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/ccr3.1290","article-title":"Fulminant hemolysis in glucose-6-phosphate dehydrogenase deficiency","volume":"6","author":"Moiz","year":"2018","journal-title":"Clin Case Rep."},{"key":"B29","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2174\/1871530317666171003160350","article-title":"Study of glucose-6-phosphate dehydrogenase deficiency: 5 years retrospective Egyptian study","volume":"18","author":"Hagag","year":"2018","journal-title":"Endocr Metab Immune Disord Drug Targets."},{"key":"B30","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1182\/asheducation-2016.1.208","article-title":"Update on the diagnosis and management of paroxysmal nocturnal hemoglobinuria","volume":"2016","author":"Parker","year":"2016","journal-title":"Hematol Am Soc Hematol Educ Program."},{"key":"B31","doi-asserted-by":"publisher","first-page":"17028","DOI":"10.1038\/nrdp.2017.28","article-title":"Paroxysmal nocturnal haemoglobinuria","volume":"3","author":"Hill","year":"2017","journal-title":"Nat Rev Dis Primers."},{"key":"B32","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2450\/2015.0249-14","article-title":"Complement-mediated haemolysis and the role of blood transfusion in paroxysmal nocturnal haemoglobinuria","volume":"13","author":"Olutogun","year":"2015","journal-title":"Blood Transfus."},{"key":"B33","doi-asserted-by":"publisher","first-page":"100648","DOI":"10.1016\/j.blre.2019.100648","article-title":"Diagnosis and treatment of autoimmune hemolytic anemia in adults: recommendations from the First International Consensus Meeting","volume":"41","author":"J\u00e4ger","year":"2020","journal-title":"Blood Rev."},{"key":"B34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2450\/2014.0252-14","article-title":"Pitfalls in the diagnosis of autoimmune haemolytic anaemia","volume":"13","author":"Barcellini","year":"2015","journal-title":"Blood Transfus."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1182\/blood-2016-11-693689","article-title":"How I treat autoimmune hemolytic anemia","volume":"129","author":"Go","year":"2017","journal-title":"Blood."},{"key":"B36","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1056\/NEJMcp1900554","article-title":"Warm autoimmune hemolytic anemia","volume":"381","author":"Brodsky","year":"2019","journal-title":"N Engl J Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1182\/asheducation-2018.1.382","article-title":"Autoimmune hemolytic anemia","volume":"2018","author":"Hill","year":"2018","journal-title":"Hematol Am Soc Hematol Educ Program."},{"key":"B38","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/j.1365-2141.1991.tb08624.x","article-title":"Autoantibodies and drug- or metabolite-dependent antibodies in patients with diclofenac-induced immune haemolysis","volume":"77","author":"Salama","year":"1991","journal-title":"Br J Haematol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1046\/j.1365-2141.1996.d01-1947.x","article-title":"Diclofenac-induced immune haemolytic anaemia: simultaneous occurrence of red blood cell autoantibodies and drug-dependent antibodies","volume":"95","author":"Salama","year":"1996","journal-title":"Br J Haematol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1046\/j.1423-0410.1997.7220121.x","article-title":"Immune complex-mediated haemolytic anaemia and Evans syndrome induced by diclofenac","volume":"72","author":"de Quir\u00f3s","year":"1997","journal-title":"Vox Sang."},{"key":"B41","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/ajh.20494","article-title":"Misdiagnosis in patients with diclofenac-induced hemolysis: new cases and a concise review","volume":"81","author":"Ahrens","year":"2006","journal-title":"Am J Hematol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"463","DOI":"10.2165\/00003088-198308060-00001","article-title":"Clinical pharmacokinetics of cimetidine","volume":"8","author":"Somogyi","year":"1983","journal-title":"Clin Pharmacokinet."},{"key":"B43","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/bjh.14654","article-title":"British society for haematology guidelines [British society for haematology guidelines]. Guidelines on the management of drug-induced immune and secondary autoimmune, haemolytic anaemia","volume":"177","author":"Hill","year":"2017","journal-title":"Br J Haematol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.723167\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T18:49:36Z","timestamp":1632768576000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.723167\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,24]]},"references-count":43,"alternative-id":["10.3389\/fmed.2021.723167"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.723167","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,24]]},"article-number":"723167"}}